Company Info






  Home > Archived Webinars >

Corruption and FCPA Violations in the Medical Device Industry



 
Our Price: $395.00

Product Code: WB-7085
Qty:

Product Info
 
About the Product
Includes 1 hour Windows Media Video File and PowerPoint presentations for immediate download.


FCPA and worldwide anti-corruption enforcement activities in the life science industry are receiving increased attention with over $142 million in fines collected by DOJ and the SEC in 2012 alone. The current list of FCPA-related investigations for medical device companies is lengthy and penalties are substantial, with Johnson & Johnson having paid out the largest settlement resulting in approximately $70 million in fines. These activities demonstrate an ongoing trend that industry legal and regulatory professionals are well aware of - they have and will continue to be subject to heavily stringent FCPA oversight. The following presentation will provide attendees with further insight into the scope, nature and influence of corruption in the life science industry, while assessing the government and regulators’ capacity to manage and mitigate corruption within the US healthcare system.
  • Update on current regulatory and enforcement activities
  • Where are FCPA violations occurring and why
  • Analysis of recent court cases and their impact - United States v. Esquenazi and United States v. Straub
  • Framing compliance programs for best practices
  • Recommendations for risk mitigation and compliance enhancement

Speaker:

Peter S. Spivack
Partner
Hogan Lovells US LLP


Participants that will find this webinar most beneficial will be those involved in medical device companies. Job titles of attendees that will be most applicable for this session will be:
  • Regulatory Affairs
  • Legal Counsel
  • Compliance


Share your knowledge of this product. Be the first to write a review »